Farms.com Home   News

One Day, Plants Could Grow Your Meds, Say U of G Researchers

“Is this insulin animal-free?” 

In a future where major medications – like insulin, cancer treatments and life-saving vaccines – are grown from plants, such a question is valid. 

Though the Canadian Food Inspection Agency has said, “There is no commercial plant molecular farming in Canada to date, and none is anticipated in the near future,” University of Guelph researchers disagree

As Dr. Jennifer Geddes-McAlister, professor in the College of Biological Science puts it, there is no reason plants should not be making our drugs right now:

“In theory, it should already be happening,” she says. “Because the promise is there. The setup and infrastructure are there. The research is there. The biggest hurdle is reducing variability in drug production.”

These are the current aims of molecular pharming, the field that uses plants, rather than costly animal cells and materials, to produce our pharmaceuticals.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.